Loading…

Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate

The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a micropart...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmaceutical sciences 2017-01, Vol.96, p.20-27
Main Authors: Sironi, Daniel, Rosenberg, Jörg, Bauer-Brandl, Annette, Brandl, Martin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3
cites cdi_FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3
container_end_page 27
container_issue
container_start_page 20
container_title European journal of pharmaceutical sciences
container_volume 96
creator Sironi, Daniel
Rosenberg, Jörg
Bauer-Brandl, Annette
Brandl, Martin
description The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a microparticle formulation (Lipidil® 200mg) and a nanoparticle formulation (LIPIDIL 145 ONE®) using a pair of side-by side diffusion cells separated by a cellulose hydrate membrane. Under such dynamic conditions, transient supersaturation arising from the nanoparticle formulation could be demonstrated for the first time. Furthermore, the dissolution-/permeation-system introduced here allowed for in-depth mechanistic insights: Biomimetic media, despite enhancing the apparent solubility of fenofibrate via micellar solubilization, did not increase permeation rate, irrespective whether the micro-/ or nanoparticle-formulation was tested. Nondissolved nano-/microparticles served as a reservoir helping to maintain high levels of molecularly dissolved drug, which in turn caused high and constant permeation rates. The micelle-bound drug may also serve as a drug-reservoir, yet of subordinate importance as long as there are nano-/microparticles present. Despite the limitations of the current experimental set-up, combined dissolution-/permeation-testing appears a valuable new tool to promote mechanistic understanding during formulation development. Last but not least, the in vitro dissolution and permeation behavior revealed here was in good qualitative agreement with human duodenal and plasma values reported in literature for the same formulations. [Display omitted]
doi_str_mv 10.1016/j.ejps.2016.09.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835379618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098716303529</els_id><sourcerecordid>1835379618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouq7-AQ_So5d2p2m3acCL-A2CF70a0mYiWdqkJq2w_97UVY-eZg7P-zLzEHKWQ5ZDXq02GW6GkNG4Z8AzgHyPLPKa8RQYhX2yAE7rFHjNjshxCBsAqGoGh-SIsjVneVksyNvN1sretIkyIbhuGo2z6WpA36P83kcMo7HvidOJldalibQqiQHvBulH03aYaOf7qfvGw8xptE6bxssRT8iBll3A05-5JK93ty_XD-nT8_3j9dVT2hbrakwRkCle8Ro0Raa1KgG1ZrJpSoVrZAwoAi8kLVmjaM1QFoy2VckKyrVqZLEkF7vewbuPKZ4sehNa7Dpp0U1B5HWxLhiv4lwSukPjCyF41GLwppd-K3IQs1exEbNXMXsVwEX0GkPnP_1T06P6i_yKjMDlDsD45adBL0Jr0LaojMd2FMqZ__q_AFayi9c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835379618</pqid></control><display><type>article</type><title>Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate</title><source>ScienceDirect Journals</source><creator>Sironi, Daniel ; Rosenberg, Jörg ; Bauer-Brandl, Annette ; Brandl, Martin</creator><creatorcontrib>Sironi, Daniel ; Rosenberg, Jörg ; Bauer-Brandl, Annette ; Brandl, Martin</creatorcontrib><description>The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a microparticle formulation (Lipidil® 200mg) and a nanoparticle formulation (LIPIDIL 145 ONE®) using a pair of side-by side diffusion cells separated by a cellulose hydrate membrane. Under such dynamic conditions, transient supersaturation arising from the nanoparticle formulation could be demonstrated for the first time. Furthermore, the dissolution-/permeation-system introduced here allowed for in-depth mechanistic insights: Biomimetic media, despite enhancing the apparent solubility of fenofibrate via micellar solubilization, did not increase permeation rate, irrespective whether the micro-/ or nanoparticle-formulation was tested. Nondissolved nano-/microparticles served as a reservoir helping to maintain high levels of molecularly dissolved drug, which in turn caused high and constant permeation rates. The micelle-bound drug may also serve as a drug-reservoir, yet of subordinate importance as long as there are nano-/microparticles present. Despite the limitations of the current experimental set-up, combined dissolution-/permeation-testing appears a valuable new tool to promote mechanistic understanding during formulation development. Last but not least, the in vitro dissolution and permeation behavior revealed here was in good qualitative agreement with human duodenal and plasma values reported in literature for the same formulations. [Display omitted]</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2016.09.001</identifier><identifier>PMID: 27597143</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Diffusion ; Dissolution/permeation ; Drug Compounding ; Drug Liberation ; Dynamic ; Enabling formulation ; Fenofibrate - chemistry ; Hypolipidemic Agents - chemistry ; Intestinal Secretions - chemistry ; Microparticle ; Nanoparticle ; Nanoparticles - chemistry ; Particle Size ; Permeability ; Solubility ; Solubilization ; Supersaturation</subject><ispartof>European journal of pharmaceutical sciences, 2017-01, Vol.96, p.20-27</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3</citedby><cites>FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3</cites><orcidid>0000-0001-9598-5508 ; 0000-0003-3561-5016</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27597143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sironi, Daniel</creatorcontrib><creatorcontrib>Rosenberg, Jörg</creatorcontrib><creatorcontrib>Bauer-Brandl, Annette</creatorcontrib><creatorcontrib>Brandl, Martin</creatorcontrib><title>Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a microparticle formulation (Lipidil® 200mg) and a nanoparticle formulation (LIPIDIL 145 ONE®) using a pair of side-by side diffusion cells separated by a cellulose hydrate membrane. Under such dynamic conditions, transient supersaturation arising from the nanoparticle formulation could be demonstrated for the first time. Furthermore, the dissolution-/permeation-system introduced here allowed for in-depth mechanistic insights: Biomimetic media, despite enhancing the apparent solubility of fenofibrate via micellar solubilization, did not increase permeation rate, irrespective whether the micro-/ or nanoparticle-formulation was tested. Nondissolved nano-/microparticles served as a reservoir helping to maintain high levels of molecularly dissolved drug, which in turn caused high and constant permeation rates. The micelle-bound drug may also serve as a drug-reservoir, yet of subordinate importance as long as there are nano-/microparticles present. Despite the limitations of the current experimental set-up, combined dissolution-/permeation-testing appears a valuable new tool to promote mechanistic understanding during formulation development. Last but not least, the in vitro dissolution and permeation behavior revealed here was in good qualitative agreement with human duodenal and plasma values reported in literature for the same formulations. [Display omitted]</description><subject>Diffusion</subject><subject>Dissolution/permeation</subject><subject>Drug Compounding</subject><subject>Drug Liberation</subject><subject>Dynamic</subject><subject>Enabling formulation</subject><subject>Fenofibrate - chemistry</subject><subject>Hypolipidemic Agents - chemistry</subject><subject>Intestinal Secretions - chemistry</subject><subject>Microparticle</subject><subject>Nanoparticle</subject><subject>Nanoparticles - chemistry</subject><subject>Particle Size</subject><subject>Permeability</subject><subject>Solubility</subject><subject>Solubilization</subject><subject>Supersaturation</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMouq7-AQ_So5d2p2m3acCL-A2CF70a0mYiWdqkJq2w_97UVY-eZg7P-zLzEHKWQ5ZDXq02GW6GkNG4Z8AzgHyPLPKa8RQYhX2yAE7rFHjNjshxCBsAqGoGh-SIsjVneVksyNvN1sretIkyIbhuGo2z6WpA36P83kcMo7HvidOJldalibQqiQHvBulH03aYaOf7qfvGw8xptE6bxssRT8iBll3A05-5JK93ty_XD-nT8_3j9dVT2hbrakwRkCle8Ro0Raa1KgG1ZrJpSoVrZAwoAi8kLVmjaM1QFoy2VckKyrVqZLEkF7vewbuPKZ4sehNa7Dpp0U1B5HWxLhiv4lwSukPjCyF41GLwppd-K3IQs1exEbNXMXsVwEX0GkPnP_1T06P6i_yKjMDlDsD45adBL0Jr0LaojMd2FMqZ__q_AFayi9c</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Sironi, Daniel</creator><creator>Rosenberg, Jörg</creator><creator>Bauer-Brandl, Annette</creator><creator>Brandl, Martin</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9598-5508</orcidid><orcidid>https://orcid.org/0000-0003-3561-5016</orcidid></search><sort><creationdate>20170101</creationdate><title>Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate</title><author>Sironi, Daniel ; Rosenberg, Jörg ; Bauer-Brandl, Annette ; Brandl, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Diffusion</topic><topic>Dissolution/permeation</topic><topic>Drug Compounding</topic><topic>Drug Liberation</topic><topic>Dynamic</topic><topic>Enabling formulation</topic><topic>Fenofibrate - chemistry</topic><topic>Hypolipidemic Agents - chemistry</topic><topic>Intestinal Secretions - chemistry</topic><topic>Microparticle</topic><topic>Nanoparticle</topic><topic>Nanoparticles - chemistry</topic><topic>Particle Size</topic><topic>Permeability</topic><topic>Solubility</topic><topic>Solubilization</topic><topic>Supersaturation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sironi, Daniel</creatorcontrib><creatorcontrib>Rosenberg, Jörg</creatorcontrib><creatorcontrib>Bauer-Brandl, Annette</creatorcontrib><creatorcontrib>Brandl, Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sironi, Daniel</au><au>Rosenberg, Jörg</au><au>Bauer-Brandl, Annette</au><au>Brandl, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>96</volume><spage>20</spage><epage>27</epage><pages>20-27</pages><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a microparticle formulation (Lipidil® 200mg) and a nanoparticle formulation (LIPIDIL 145 ONE®) using a pair of side-by side diffusion cells separated by a cellulose hydrate membrane. Under such dynamic conditions, transient supersaturation arising from the nanoparticle formulation could be demonstrated for the first time. Furthermore, the dissolution-/permeation-system introduced here allowed for in-depth mechanistic insights: Biomimetic media, despite enhancing the apparent solubility of fenofibrate via micellar solubilization, did not increase permeation rate, irrespective whether the micro-/ or nanoparticle-formulation was tested. Nondissolved nano-/microparticles served as a reservoir helping to maintain high levels of molecularly dissolved drug, which in turn caused high and constant permeation rates. The micelle-bound drug may also serve as a drug-reservoir, yet of subordinate importance as long as there are nano-/microparticles present. Despite the limitations of the current experimental set-up, combined dissolution-/permeation-testing appears a valuable new tool to promote mechanistic understanding during formulation development. Last but not least, the in vitro dissolution and permeation behavior revealed here was in good qualitative agreement with human duodenal and plasma values reported in literature for the same formulations. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27597143</pmid><doi>10.1016/j.ejps.2016.09.001</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-9598-5508</orcidid><orcidid>https://orcid.org/0000-0003-3561-5016</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0928-0987
ispartof European journal of pharmaceutical sciences, 2017-01, Vol.96, p.20-27
issn 0928-0987
1879-0720
language eng
recordid cdi_proquest_miscellaneous_1835379618
source ScienceDirect Journals
subjects Diffusion
Dissolution/permeation
Drug Compounding
Drug Liberation
Dynamic
Enabling formulation
Fenofibrate - chemistry
Hypolipidemic Agents - chemistry
Intestinal Secretions - chemistry
Microparticle
Nanoparticle
Nanoparticles - chemistry
Particle Size
Permeability
Solubility
Solubilization
Supersaturation
title Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T10%3A21%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dynamic%20dissolution-/permeation-testing%20of%20nano-%20and%20microparticle%20formulations%20of%20fenofibrate&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Sironi,%20Daniel&rft.date=2017-01-01&rft.volume=96&rft.spage=20&rft.epage=27&rft.pages=20-27&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2016.09.001&rft_dat=%3Cproquest_cross%3E1835379618%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835379618&rft_id=info:pmid/27597143&rfr_iscdi=true